Antazol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antazol

Antazol is a foundational medicine designed for symptomatic relief of nasal congestion, acting directly on the nasal passages to restore clearer breathing. Its primary component, Xylometazoline hydrochloride, defines its identity as a single-ingredient product. Understanding Antazol begins with recognizing its distinct pharmacological category and targeted delivery system.

Property Description
Active ingredient Xylometazoline hydrochloride
Form Nasal Drops or Nasal Spray Solution
Pharmacological class Sympathomimetic Agent / Alpha-adrenergic Agonist
Common use Symptomatic relief of nasal congestion
Origin Synthetic Imidazoline Derivative

Antazol: A Definition and Pharmacological Classification

Antazol is defined pharmacologically as a sympathomimetic agent and a potent alpha-adrenergic receptor agonist. This classification places it firmly within the therapeutic group of nasal decongestants. The medicine’s core functionality is well-established, confirming its role in medical practice.

Its active ingredient, Xylometazoline hydrochloride, is a chemically synthesized imidazoline derivative. This compound is recognized for its marked alpha-adrenergic activity which enables its direct effect on blood vessels. The drug is classified by its action, which is designed to mimic natural body chemicals that control localized vascular tone.


What is Antazol’s Composition and Form?

Antazol is a topical nasal preparation, meaning it is applied locally to the nasal lining where it is needed. It is typically supplied as a solution for intranasal use, delivered as either nasal drops or a nasal spray. The brand often targets different patient groups by offering specialized lower concentrations for children alongside the standard solution for adults.

The composition centers on the Xylometazoline hydrochloride dissolved in an aqueous solution, a water-based vehicle that facilitates effective dispersion across the nasal mucosa. The medicine is structurally designed for localized impact, ensuring its mechanism is concentrated precisely on the tissues of the nose and pharynx.


What is the General Purpose of Antazol?

The general purpose of Antazol is to counter the swelling that causes a blocked nose by inducing vasoconstriction. By stimulating the alpha-adrenergic receptors, Xylometazoline causes the blood vessels in the nasal lining to narrow. This vasoconstriction rapidly reduces blood flow to the area, shrinking the swollen tissues and lowering the edema that restricts airflow. This action successfully opens the nasal passages, with the overall benefit being the restoration of comfortable airflow for the patient.

Regulatory References

  1. Xylometazoline Nasal (DailyMed, NIH)
  2. Xylometazoline in WHO Essential Medicines List (eEML)

What side effects are possible with Antazol?

Possible Side Effects and Safety Information

The official safety profile for Antazol (Xylometazoline) details adverse reactions and usage constraints as categorized by government health authorities. These effects are formally classified based on observed frequency and the body system affected, ensuring a neutral, non-advisory description of the medicine's risk profile.

Adverse reactions may be broadly grouped into local and systemic effects, according to regulatory documents.

Officially Classified Adverse Reactions

Frequency Classification Examples of Documented Effects
Common Nasal dryness, burning sensation, nasal discomfort, headache, application site irritation.
Uncommon Epistaxis (nosebleed).
Very Rare Transient visual impairment, heart rate irregular or increased, hypersensitivity reactions.

Effects on the Nervous System may include anxiety, restlessness, insomnia, and irritability, while Cardiac Disorders are associated with changes in heart rate. These systemic effects, along with others like hallucinations or paranoid delusions, are explicitly documented as linked to prolonged or excessive use.

Safety Considerations and Restrictions

Specific safety considerations apply to patients with pre-existing conditions. Regulatory texts advise caution in individuals with hypertension, cardiovascular disease, hyperthyroidism, diabetes mellitus, and narrow-angle glaucoma. Furthermore, the medicine is contraindicated (must not be used) in patients with conditions like atrophic rhinitis, rhinitis sicca, or following specific surgical procedures that expose the dura mater.

A recognized pattern associated with extended use is the development of rebound congestion (Rhinitis medicamentosa) and tolerance with diminished effect, which affects the nasal mucosa.

Overdose and Emergency Response

Official Documentation of Antazol Overdose

Regulatory labeling confirms that overdose of Antazol (Xylometazoline hydrochloride), typically following excessive administration or accidental ingestion, can result in severe systemic effects that warrant immediate medical attention. The clinical picture is characterized by documented effects on the Central Nervous System (CNS) and Cardiovascular System.

Documented Manifestations and Severe Outcomes: Overdose presentations include severe dizziness, headache, somnolence, lethargy, and agitation. Systemic cardiovascular effects such as bradycardia (slow heart rate) and hypertension (high blood pressure) may occur, which can subsequently transition to hypotension. Severe overdose may lead to critical outcomes including convulsions, coma, and respiratory depression.

When to Seek Immediate Medical Help: Due to the risk of life-threatening events, official regulatory guidance mandates that individuals must seek emergency medical care immediately upon suspicion of an overdose or accidental ingestion. Urgent symptomatic treatment under medical supervision is required for management.

Population-Specific Considerations: Regulatory documentation explicitly notes that small children are more sensitive to toxicity than adults. Overdose in infants and young children is associated with a serious risk of CNS depression and apnoea (cessation of breathing). Management involves initiating appropriate supportive measures and requires observation of the individual for several hours, as no specific antidote is known.

Therapeutic Uses of Antazol

Antazol is commonly used across conditions presenting with acute episodes of nasal discomfort. It may be part of symptomatic management for temporary nasal congestion due to several conditions, including the common cold, hay fever, or other respiratory allergies.

This medication is applied in clinical settings that involve acute or unstable symptom patterns, such as during acute rhinitis or when sinus pressure arises from obstructed drainage pathways secondary to nasal swelling. It helps address symptom clusters that may become intense or disruptive and is applied in addressing the physical discomfort and swelling of the nasal lining.

“It supports the patient during difficult episodes by easing distress related to significant discomfort and assists with maintaining functional stability, contributing to improved comfort during periods of heightened symptoms.”

This supportive relief generally contributes to easing the overall symptom load when congestion interferes with daily functioning. Applied during phases of increased distress or discomfort, Antazol is useful in scenarios where symptoms escalate temporarily, allowing patients to maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Relief for Nasal Obstruction The medication is considered relevant when short-term symptomatic assistance is needed to counter swelling of nasal tissues and contributes to improved breathing during symptomatic phases.

Regulatory References

  1. DailyMed NLM/NIH Overview of Xylometazoline

Eligibility and Restrictions for Use

Who Can and Cannot Use Antazol?

The population eligibility for Antazol (Xylometazoline hydrochloride) is strictly defined by regulatory authorities and centers on age, underlying health conditions, and physiological status.


Contraindications and Restricted Populations

Absolute Contraindications (Must Not Use):

Condition / Population
Patients with narrow-angle glaucoma or rhinitis sicca (dry nasal lining).
Patients following transsphenoidal hypophysectomy or surgery exposing the dura mater.
Patients with known hypersensitivity to Xylometazoline.
Use with or within 14 days of stopping Monoamine Oxidase Inhibitors (MAOIs).

Age-Related Eligibility:

Age Group Eligibility Status
Infants and Children under 2 years Contraindicated in most formulations.
Children 2 to 11 years Eligible only for lower concentration (e.g., 0.05%).
Adults and Adolescents (12+ years) Eligible for standard concentration (e.g., 0.1%).

Conditional Use (Use with Caution):

Patients with severe cardiovascular disorders (e.g., hypertension, Long QT syndrome), hyperthyroidism, diabetes mellitus, and prostatic hypertrophy are generally subject to conditional use requirements as the drug's sympathomimetic action may pose risks. Use during pregnancy and lactation is generally not recommended or advised only under strict medical supervision due to the potential for systemic vasoconstrictive effects.

What should I know about interactions with other medicines?

Antazol, which contains the active substance xylometazoline, is a topical decongestant. While intended for local action in the nose, the medicine can be absorbed into the bloodstream, leading to potential systemic interactions with other medicines.

Contraindicated and High-Risk Combinations

The most significant and often contraindicated interaction is with Monoamine Oxidase Inhibitors (MAOIs), including isocarboxazid, tranylcypromine, phenelzine, and linezolid (an antibiotic with MAOI activity). Combining xylometazoline with MAOIs, or using it within 14 days of stopping an MAOI, can lead to a severe and potentially life-threatening rise in blood pressure, known as a hypertensive crisis.

Combinations Requiring Caution

Caution is generally required when using Antazol alongside medicines that increase blood pressure or heart rate, such as other sympathomimetics (including other decongestants), and certain tricyclic antidepressants (e.g., amitriptyline, imipramine) or tetracyclic antidepressants (e.g., amoxapine). These combinations can increase the risk of side effects like elevated blood pressure, fast or irregular heartbeat, or palpitations, due to the additive nature of their effects on the cardiovascular system.

Patients with pre-existing conditions like high blood pressure, heart disease, hyperthyroidism, or diabetes should be particularly cautious, as the systemic absorption of the decongestant can exacerbate these conditions. Always consult a healthcare professional regarding all other medicines or products currently in use, including over-the-counter and herbal preparations.

Mechanism of Action

How Antazol Works

Antazol operates by engaging specific molecular targets to regulate physiological signaling pathways, resulting in a controlled modification of the cellular signaling environment. The drug exhibits selective accumulation in targeted tissues, where it initiates its pharmacodynamic action.

Modulating Receptor-Mediated Signaling

Antazol acts within domains involving receptor-mediated signaling by binding to or modulating the activity of key membrane receptors. This engagement initiates or suppresses specific signaling sequences, contributing to the modulation of heightened signaling output by altering the magnitude of the signal transduction cascade.

Regulating Enzyme-Driven Pathways

The compound engages mechanisms that regulate specific enzyme-driven pathways. By modifying early molecular steps within these cascades, Antazol is involved in systems where targeted pathway adjustment is required, resulting in the reduced synthesis or activity of target mediators.

Influencing Feedback Regulation

Antazol affects biological systems where specific transmitters or mediators dominate, influencing feedback regulation within pathways. This action influences regulatory mechanisms that govern pathway activity, culminating in an altered steady-state concentration or activity of downstream effectors within the targeted biological pathways.

Dosage and Administration Information

How to Use Antazol — Official Administration Guidelines

Antazol is for nasal use only, administered as drops or a spray. The correct concentration and frequency must be chosen based on the patient's age and the specific product formula to adhere to official instructions for use.


Official Dosing Rules (Nasal Drops)

The medicine is supplied in two concentrations, 0.1% (Adult formula) and 0.05% (Children's formula). The 0.1% formula must not be used for children under 12 years of age.

Age Group Formula (Concentration) Recommended Dosing (Drops) Frequency Restriction
Adults (>12 years) 0.1% 2 or 3 drops in each nostril 2 to 3 times daily Do not use for children < 12 years
Children (6 to 12 years) 0.05% 2 or 3 drops in each nostril 2 or 3 times daily -
Children (<6 years) 0.05% 1 drop in each nostril 2 or 3 times daily Not to be used in infants < 3 months

Duration and Hygiene Instructions

  • Duration: The medicine must not be used for more than seven consecutive days.
  • Hygiene: For reasons of hygiene and to prevent cross-infection, each bottle must be used by one person only.
  • Product Lifespan: The opened bottle must be discarded after 28 days.

Administration Procedure

Before administering drops, gently blow your nose to clear the nostrils. Tilt your head back and place the specified number of drops into the affected nostril. To prevent contamination, avoid touching the dropper tip to the nose or any surface.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Antazol


Evidence for Symptom Relief during the Common Cold

Research examining the use of Antazol in conditions characterized by fluctuating or episodic manifestations like the common cold primarily relies on Randomized Controlled Trials (RCTs). These short-term studies were conducted during periods of increased symptom activity. Research examined populations of adults experiencing congestion associated with the common cold.

Studies monitored patient-reported outcomes describing perceived discomfort related to nasal blockage, as well as objective airflow measurements. Findings describe patterns observed in the studies related to objective airflow measurements and patient-reported shifts in the perception of a blocked nose. Long-term effects are not fully established because the follow-up durations were limited, typically lasting only 5 to 7 days.


Research on Congestion Related to Allergies and Sinus Pressure

Antazol was evaluated in studies relevant to conditions involving periods of heightened symptoms, such as congestion linked to hay fever or other respiratory allergies. Regulatory summaries utilize research describing observed physiological patterns that were explored in relation to managing localized swelling and obstruction. Research primarily reflects short-term use scenarios explored in managing acute, episodic symptoms.

Research exploring outcomes related to temporary physiological changes in drainage pathways generally relies on data established in acute congestion studies. Evidence contributes to understanding symptom patterns, but the extent of certainty is often limited regarding direct comparisons against alternative pharmacological approaches in dedicated trials.


Research Evidence in Subgroups and Special Populations

Evidence primarily covers the adult population. Research has also examined the lower concentration formulations for children, focusing on patient populations within specific age ranges and appropriate concentration limits. Data for certain groups remain insufficient, and the results apply only to the populations studied. This means findings describe group patterns, not personal outcomes, particularly for groups with complex comorbidities or specific long-term respiratory conditions.

Key Studies & References DailyMed Labeling Information for Xylometazoline Hydrochloride Solution

Frequently Asked Questions (FAQ)

Common questions about Antazol (FAQ)


Q: How quickly does Antazol start working after the first use?

Official product information often describes the onset of action as fast-acting, noting relief may be observed within 5 to 10 minutes after the medicine is administered. This time frame is established in studies examining the drug's effect on nasal airflow.


Q: What is the typical duration of action for one dose of Antazol?

The effect of a single dose is generally described in official dosing documentation to last for up to 10 to 12 hours. This duration is consistent with the official instructions regarding recommended frequency of use.


Q: Is it possible to become dependent on using Antazol?

Official safety warnings describe a pattern associated with frequent or prolonged use that is sometimes referred to by users as dependence. This phenomenon, known as rebound congestion (Rhinitis medicamentosa), means the nasal congestion may return or worsen after stopping the medicine. Prolonged use is also noted to lead to a diminished effect (tolerance).


Q: Does using Antazol affect my ability to drive or operate machinery?

Warnings address potential systemic side effects, including effects on the nervous system (e.g., restlessness, anxiety), dizziness, or, very rarely, transient visual impairment. If a person experiences any of these effects, the ability to drive or operate machinery may potentially be affected.


Q: How does the medicine in Antazol work to reduce nasal swelling?

Antazol is classified as a sympathomimetic agent, meaning it acts by mimicking certain natural body chemicals. It works directly on the lining of the nose to cause vasoconstriction, which is the narrowing of the blood vessels. This action reduces swelling in the nasal tissues, which in turn restores comfortable airflow.


Q: Can Antazol be used for congestion caused by a common cold?

Official labeling states that a purpose of the medicine includes the symptomatic relief of nasal congestion due to the common cold. The medicine is intended to temporarily help clear nasal passages.


Q: Can Antazol be used for congestion due to allergies or hay fever?

Official product information includes the symptomatic relief of nasal congestion that may be caused by conditions such as hay fever and other upper respiratory allergies. It provides temporary relief from the associated swelling and blockage.


Q: What is the difference between Antazol and a saline nasal spray?

Antazol is defined as a sympathomimetic decongestant, meaning it contains a potent active ingredient (Xylometazoline) that chemically constricts blood vessels to actively reduce swelling. In contrast, a saline nasal spray is typically a simple saltwater solution used for moisturizing the nasal passages or washing away mucus.


Q: Is Antazol the same as other decongestant nasal sprays like Oxymetazoline?

Antazol contains the active ingredient Xylometazoline. While it belongs to the same general pharmacological class (sympathomimetics) as other decongestants, such as those containing Oxymetazoline, the two are different chemical compounds. Official documents refer to them as similar agents that act on the same target receptors.


Q: Can Antazol be used to treat a chronic stuffy nose?

Regulatory documents explicitly state that the medicine must not be used for more than three to seven consecutive days. This duration restriction reflects the risk of rebound congestion associated with prolonged use.


Q: Is Antazol safe to use during pregnancy?

Official product labeling advises that if a person is pregnant, they should ask a health professional before use. This guidance reflects the need for careful consideration and medical supervision during pregnancy.


Q: Are there special precautions for using Antazol while breastfeeding?

Similar to use during pregnancy, official labeling advises that if a person is breast-feeding, they should ask a health professional before use. The need for caution and oversight by a healthcare professional is emphasized.


Q: Does Antazol interact with any common over-the-counter pain relievers or cold medicines?

Regulatory warnings focus on potential interactions with other medicines that have sympathomimetic properties, which includes some common cold and allergy preparations. Warnings also advise caution when used alongside medicines that can increase blood pressure. Official warnings note the importance of consulting a health professional about all other medicines, including over-the-counter and herbal preparations.


Q: What types of prescription medications may interact with Antazol?

Official warnings describe a major contraindication with Monoamine Oxidase Inhibitors (MAOIs), which are certain types of antidepressants. Caution is also advised when using it with other medicines that can increase blood pressure or heart rate, such as certain tricyclic antidepressants and other sympathomimetics.


Q: Is there a known interaction between Antazol and alcohol?

Topical nasal Xylometazoline is generally reported by regulatory drug interaction checkers to have no known direct interaction with alcohol (ethanol). However, the general risk of the medicine being absorbed into the bloodstream warrants consultation with a health professional.


Q: Can Antazol be used alongside a steroid nasal spray?

General regulatory advisories warn against mixing different nasal spray preparations concurrently. However, medical literature, consistent with regulatory practice, notes that corticosteroids are sometimes used in management protocols related to long-term decongestant side effects.


Q: Is the low-dose formulation of Antazol still effective for adults?

Official dosage guidelines specify the 0.1% concentration for adults (12 years and over) and the 0.05% concentration for children. These different concentrations are specifically intended for their respective age groups according to regulatory approval, ensuring appropriate effect for the designated user.


Q: Can I use Antazol if I have a history of nosebleeds (epistaxis)?

Official safety documents list epistaxis (nosebleed) as an Uncommon adverse reaction, meaning it is a documented, though infrequent, side effect. Regulatory documents do not include an explicit contraindication for use based solely on a person's history of nosebleeds.


Q: Is Antazol available as a generic medication?

The active ingredient in Antazol, Xylometazoline, is widely available under various generic and branded names internationally. It is a well-established compound in the medical community.


Q: Do you need a prescription to get Antazol?

In many regions, the active ingredient Xylometazoline is classified as an Over-the-Counter (OTC) medicine. This means it can often be purchased directly without the need for a prescription from a healthcare provider.


Q: What does the term 'sympathomimetic agent' mean in relation to Antazol?

A sympathomimetic agent is the pharmacological class that Antazol belongs to. It describes a medicine that mimics the action of certain natural body chemicals, like adrenaline, to cause effects such as the narrowing of blood vessels (vasoconstriction) in the nasal lining.


Q: Can I use Antazol if I also take a lot of vitamins or herbal supplements?

Official warnings note the importance of consulting a health professional about all medicines, including any vitamins or herbal preparations. This is noted due to the potential for the medicine to be absorbed into the system and possibly interact with other compounds.


Q: Can the effectiveness of Antazol decrease over time?

Official warnings describe a recognized pattern associated with extended or frequent use that involves tolerance with diminished effect. This means that if used too often or for too long, the medicine may become less effective at relieving congestion.

How should Antazol be stored and disposed of?

How to Store and Dispose of Antazol

Official regulatory guidelines establish specific storage and disposal requirements for Antazol (Xylometazoline Hydrochloride) to maintain product stability and ensure safety.


Storage Conditions and Stability

  • Temperature and Environment: The medicine must be stored at a temperature not above 25mathrmC and protected from heat, light, and freezing. It should be kept in its original container and maintained in a cool, dry place.
  • Post-Opening Stability: The nasal solution must be discarded after 28 days of first opening, as defined by official regulatory labeling, regardless of the overall expiration date.
  • Child Safety: Antazol must be stored out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

  • Unused or expired product should be disposed of in accordance with local requirements. Official regulatory guidance advises against disposal via wastewater or typical household trash unless following explicit governmental drug disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antazol found in:

A-Z Index: